Dare Bioscience, Inc. ( DARE) - Key Metrics
DARE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0 | -$0.28 | -$0.03 | -$0.05 |
| 2025Q2 | $0 | -$0.45 | -$0.61 | -$0.59 |
| 2025Q1 | $0 | -$0.50 | -$0.62 | -$0.64 |
DARE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -1.88 |
| 2025Q2 | ? | -1.32 |
| 2025Q1 | ? | -1.45 |
DARE Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -20.89% | ? |
| 2025Q4 | 4.42% | ? |
| 2025Q3 | -2.30% | ? |
| 2025Q2 | -24.83% | ? |
| 2025Q1 | -22.23% | ? |
DARE
Price: $1.28
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.91 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 165200
Ebitda: -1.3 millionMarket Capitalization: 19.8 million